Ninety One (UK)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7M Buy
98,910
+2,009
+2% +$235K 0.03% 170
2026
Q1
$11.7M Sell
96,901
-21,989
-18% -$2.54M 0.03% 159
2025
Q4
$12.5M Sell
118,890
-14,696
-11% -$1.38M 0.03% 163
2025
Q3
$11.2M Buy
133,586
+42,007
+46% +$3.46M 0.02% 168
2025
Q2
$7.25M Buy
91,579
+34,884
+62% +$2.77M 0.02% 172
2025
Q1
$5.09M Buy
56,695
+11,708
+26% +$1.09M 0.01% 170
2024
Q4
$4.48M Hold
44,987
0.01% 168
2024
Q3
$5.11M Hold
44,987
0.01% 166
2024
Q2
$5.57M Sell
44,987
-21,631
-32% -$2.79M 0.02% 162
2024
Q1
$8.79M Sell
66,618
-947
-1% -$117K 0.02% 158
2023
Q4
$7.37M Buy
+67,565
New +$7.01M 0.02% 154
2021
Q4
Sell
-1,332,411
Closed -$100M 215
2021
Q3
$100M Buy
1,332,411
+12,730
+1% +$968K 0.26% 95
2021
Q2
$103M Buy
1,319,681
+654,599
+98% +$48.7M 0.27% 96
2021
Q1
$48.9M Sell
665,082
-13,091
-2% -$966K 0.14% 133
2020
Q4
$52.9M Sell
678,173
-294,174
-30% -$22.5M 0.16% 124
2020
Q3
$77M Sell
972,347
-2,614,947
-73% -$205M 0.28% 83
2020
Q2
$265M Sell
3,587,294
-87,965
-2% -$6.62M 0.94% 34
2020
Q1
$270M Sell
3,675,259
-375,589
-9% -$29.5M 1.14% 25
2019
Q4
$352M Sell
4,050,848
-134,419
-3% -$11M 1.17% 25
2019
Q3
$336M Sell
4,185,267
-788,851
-16% -$63.2M 1.31% 22
2019
Q2
$398M Buy
4,974,118
+19,635
+0.4% +$1.5M 1.51% 17
2019
Q1
$393M Sell
4,954,483
-299,170
-6% -$22.4M 1.56% 16
2018
Q4
$383M Buy
5,253,653
+1,040,423
+25% +$73.4M 1.65% 12
2018
Q3
$285M Buy
4,213,230
+968,614
+30% +$61.7M 1.06% 30
2018
Q2
$188M Buy
3,244,616
+3,171,213
+4,320% +$179M 0.93% 30
2018
Q1
$3.81M Sell
73,403
-92
-0.1% -$4.97K 0.02% 204
2017
Q4
$3.95M Sell
73,495
-3,226
-4% -$179K 0.02% 239
2017
Q3
$4.69M Sell
76,721
-2,534
-3% -$154K 0.02% 230
2017
Q2
$4.85M Sell
79,255
-52,499
-40% -$3.2M 0.02% 224
2017
Q1
$7.99M Buy
131,754
+9,711
+8% +$589K 0.04% 196
2016
Q4
$6.86M Buy
122,043
+754
+0.6% +$44.1K 0.04% 189
2016
Q3
$7.22M Sell
121,289
-1,413
-1% -$82.6K 0.04% 203
2016
Q2
$6.75M Sell
122,702
-2,308
-2% -$123K 0.03% 207
2016
Q1
$6.31M Sell
125,010
-158,340
-56% -$7.75M 0.03% 213
2015
Q4
$14.3M Sell
283,350
-1,936
-0.7% -$97.6K 0.08% 152
2015
Q3
$13.4M Sell
285,286
-7,825
-3% -$416K 0.08% 155
2015
Q2
$15.9M Sell
293,111
-42,997
-13% -$2.41M 0.09% 155
2015
Q1
$18.4M Sell
336,108
-100,360
-23% -$5.68M 0.11% 144
2014
Q4
$23.7M Buy
436,468
+12,133
+3% +$676K 0.14% 134
2014
Q3
$24M Buy
424,335
+10,431
+3% +$586K 0.14% 140
2014
Q2
$22.8M Sell
413,904
-132,538
-24% -$7.23M 0.13% 145
2014
Q1
$29.6M Buy
546,442
+18,047
+3% +$935K 0.2% 122
2013
Q4
$25.2M Sell
528,395
-86,563
-14% -$3.96M 0.18% 119
2013
Q3
$27.9M Sell
614,958
-25,013
-4% -$1.14M 0.21% 112
2013
Q2
$28.4M Buy
+639,971
New +$28.6M 0.22% 114

Other funds holding MRK

Ninety One (UK)'s MRK Position: Q2 2026 in Review

Ninety One (UK) increased its Merck (MRK) stake by 2.1% in Q2 2026, buying an estimated $235K and bringing the position to 98,910 shares worth $12.7M. The position accounts for 0.03% of the portfolio, ranked #170.

Ninety One (UK) first reported a position in MRK in Q2 2013 and has held it in 45 quarters since. The position peaked at $398M in Q2 2019. 1,116 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Ninety One (UK) held 98,910 shares of Merck worth $12.7M as of Q2 2026.
  • Ninety One (UK) bought 2,009 Merck shares in Q2 2026, an estimated $235K.
  • Merck made up 0.03% of Ninety One (UK)'s portfolio in Q2 2026, its #170 holding.
  • Ninety One (UK) first reported a position in Merck in Q2 2013 and has held it in 45 quarters since.
  • Ninety One (UK)'s Merck position peaked at $398M in Q2 2019.
  • 1,116 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Ninety One (UK)'s 13F filing for Q2 2026, filed 16 Jul 2026.